# FDA 483 - Sichuan D-Innovation Pharmaceutical Co., Ltd. - March 14, 2025

Source: https://www.keypedia.com/records/483/sichuan-d-innovation-pharmaceutical-co-ltd/aa8f3e3f-30dc-41f9-9aca-792b50ab86ed

> FDA 483 for Sichuan D-Innovation Pharmaceutical Co., Ltd. on March 14, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Sichuan D-Innovation Pharmaceutical Co., Ltd.
- Inspection Date: 2025-03-14
- Product Type: drugs
- Office Name: Office of Partnerships
- Summary: An FDA inspection of Sichuan D-Innovation Pharmaceutical Co., Ltd. in Meishan City, China, revealed significant deficiencies in their manufacturing processes. The firm failed to adequately validate production systems and evaluate deviations from specified process steps. Additionally, there was no assurance that critical systems used for API manufacture were adequately qualified for their intended use.

## Related Officers

- [Adetutu M. Gidado](https://www.keypedia.com/people/adetutu-m-gidado/6c4e8cf3-0eea-4903-9ca5-e8e2d683621d)

Company: https://www.keypedia.com/companies/sichuan-d-innovation-pharmaceutical-co-ltd/fa0d909c-6a80-4e88-ae54-6d993e083a7c

Office: https://www.keypedia.com/offices/office-of-partnerships/83acc701-fc5a-4876-bb34-7499e31541d3